https://www.zacks.com/stock/news/2221272/under-armour-uaa-to-post-q3-earnings-here-s-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2221272
Feb 05, 2024 - Under Armour's (UAA) third-quarter fiscal 2024 results are expected to reflect challenges in the North America market. However, its focus on growth strategies is likely to have aided.
zc:-8788145687630850940
0
https://www.zacks.com/stock/news/2221240/wynn-resorts-wynn-to-post-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2221240
Feb 05, 2024 - Wynn Resorts' (WYNN) fourth-quarter 2023 performance is likely to have benefited from its Macau operations, sports-betting expansion and non-gaming revenue boosting strategies.
zc:2673393193681822181
0
https://www.zacks.com/stock/news/2221181/bio-rad-laboratories-bio-to-post-q4-earnings-what-awaits?cid=CS-ZC-FT-analyst_blog|earnings_preview-2221181
Feb 05, 2024 - Ongoing weakness in the biopharma end markets, impacting the sales of Life Science tools and bioprocessing products, are likely to have impeded Bio-Rad's (BIO) Q4 revenues.
zc:-3836222881949672549
0
https://www.zacks.com/stock/news/2221182/mattel-mat-to-post-q4-earnings-here-s-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2221182
Feb 05, 2024 - Mattel's (MAT) fourth-quarter performance is likely to have benefited from a robust product line-up, IP-driven strategy and cost-control efforts.
zc:1381673643409617182
0
https://www.zacks.com/stock/news/2221180/encompass-health-ehc-to-post-q4-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2221180
Feb 05, 2024 - Encompass Health's (EHC) fourth-quarter results are likely to reflect pricing increases and growing volumes.
zc:4466983977955815392
0
https://seekingalpha.com/article/4667245-us-weekly-fundflows-insight-report-shortintermediate-government-and-treasury-etfs-post-largest-outflow-on-record?source=feed_tag_etf_portfolio_strategy
Feb 02, 2024 - At the close of LSEG Lipper’s fund-flows week, U.S. broad-based equity indices reported mixed to negative returns.
0
sa:-7910337874979433039
0
https://www.cnbc.com/2024/02/02/bristol-myers-squibb-bmy-q4-earnings-report-2023.html
Feb 02, 2024 - Bristol Myers Squibb also issued its full-year 2024 forecast, which was generally in line with expectations.
0
cnbc:5865826120474640758
0
https://www.zacks.com/stock/news/2220524/post-holdings-post-q1-earnings-beat-estimates-sales-up-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2220524
Feb 02, 2024 - Post Holdings (POST) reports strong Q1 fiscal 2024 results, with sales and earnings increasing and beating estimates. Adjusted EBITDA rises, with positive outlook ahead.
zc:-839022467035745975
0
https://www.zacks.com/stock/news/2219938/post-holdings-post-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2219938
Feb 01, 2024 - While the top- and bottom-line numbers for Post Holdings (POST) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-4940023813535408459
0
https://www.zacks.com/stock/news/2219933/post-holdings-post-q1-earnings-and-revenues-top-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2219933
Feb 01, 2024 - Post Holdings (POST) delivered earnings and revenue surprises of 57.94% and 2.22%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:1928845243027090072
0